1 / 28

Stigma

Stigma. Dr. Oliver Aldridge Edinburgh, Midlothian & East Lothian DTTO I and DTTO II. Outline. Theory Client Communication Agency Conclusions. Stigma is here to stay. Ancient Greeks physically scarred people to permanently “mark” them

ziven
Download Presentation

Stigma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Stigma Dr. Oliver Aldridge Edinburgh, Midlothian & East Lothian DTTO I and DTTO II

  2. Outline • Theory • Client • Communication • Agency • Conclusions

  3. Stigma is here to stay • Ancient Greeks physically scarred people to permanently “mark” them • Today: amputation of a finger to denote someone who is deemed to be a “grass” • May be part of the survival mechanism of group living • Some of the original driving force behind drugs legislation – San Francisco 1865

  4. Stigma needs to be Managed

  5. Why do we stigmatise? • Reciprocity • Threat: housing, benefits, treatment/support, theft, “infecting others” by introducing to drugs. • Downward comparison • Belief in a “Just” world/ “Protestant Work Ethic” – you get what you deserve and you deserve what you get

  6. Stereotyping • Drug users are bad parents • Drug users are dishonest • Drug users are manipulative • Drug users are self-indulgent • Drug users are wasters • Drug users destroy communities • Drug users choose to be drug users

  7. Linking Stereotyping & Stigmatisation • Stereotyping facilitates stigmatisation • Stigmatisation encourages stereotyping • May be linked to depersonalisation

  8. Client

  9. Individualise Management • Needs to be openly discussed so that it can be managed on an individual level. • Differing levels of stigma sensitivity between clients • Cannot make automatic assumptions about the effect on a client • Cannot make automatic assumptions about the main sources of stigma

  10. Complex Origins of Stigma Usually drug use is only one factor: • Poverty • Poor education • Unemployment • Criminal record • Drug taking • Injecting • Parenting

  11. Pre-drug History • Difficult childhood • Learning difficulties • May contribute to feeling excluded • Social acceptance may be sought in a marginalised peer group • As part of that group, drug taking/experimenting may be the norm • Effect of criminalising groups?

  12. Managing Stigma • Physical Signs • Treatment Stigmata • Social Stigmata

  13. Physical • Visible signs of drug use include:Injection sitesPoor dentitionPoor nutritionAppearing intoxicated/withdrawn • Managing these appropriately may increase the range of options in managing stigma

  14. Kenny Rogers • You’ve got to know when to hold ‘em…..Know when to fold ‘em….. • Managing disclosure is a highly individual, situation specific problem • If stigma is not overtly discussed, it is not possible to devise an effective, individualised strategy to deal with it

  15. Risk of Entering Treatment • Exposure of a previously, largely hidden level of drug use • Loss of employment • Peer group rejection • Relationship breakdown • Increased intervention e.g. Children & Families • Labelling • Disempowerment • Social Isolation

  16. Treatment Associated Stigma • Local vs. Centralised treatment services – pros and cons • Failing to treat people holistically • Perpetuating or increasing stigma in the treatment environment • Recovery = Abstinence • Information sharing vs. “raw data” being communicated to people without specialist knowledge

  17. Treatment Options • Some treatment options may feel less stigmatising to the client e.g. DHC vs. Methadone • Treatment needs to have a solid evidence base and be effective and appropriate for the client at that time

  18. Supervised Consumption of Methadone • May be stigmatising • Alterations to pharmacy may impact positively • May reduce stigma • Effect is individual and, therefore, policy should allow individual assessment/decision making

  19. Testing • Method – supervised urine collection processes • Rationale – is it being done to “catch” people? • What is the context of a result? • May help to combat negative attitudes

  20. Social Stigmata • Wraparound care essential • Helping people integrate into new social groups • The role of “ex-user” does not work for everyone

  21. Education & Communication

  22. As specialist agencies we have a responsibility to provide good quality, objective information to: • Communities • Media • Government • Professionals • Students

  23. Aetiology of Addiction • Views/hypotheses may impact on stigmatisation • Is it better to be viewed as someone with a genetically determined problem or as someone with a social problem?

  24. Dissonance • Facilitating appropriate contact with people who don’t conform to stereotypical views may catalyse change • Caveat: Stigmatisation may paradoxically be increased by contact with someone who is massively different to the stereotypical view • Does the “exception” prove the “rule”?

  25. Agency Stigmatisation

  26. Agency • May be stigmatised by the communities in which it works – “NIMBYism” • Workers may need support – e.g. outreach, needle exchange workers • Related professionals/disciplines may stigmatise those who work in this field • We may stigmatise each other by perpetuating false debates e.g. Harm Reduction vs. Abstinence • Funding wars may increase stigmatisation by threatening survival

  27. Conclusions • Stigma is here to stay – we have to learn to manage it effectively • Management of stigma has to be individualised • Stigma cannot be dealt with if it’s not openly addressed • Treatment can contribute to stigmatisation: agencies need to consider this in service planning/delivery • Commissioning needs to look at the range of treatment services available to increase choice • Agencies have to play a positive role in educating/communicating

More Related